Purpose
Neuropsychiatric care involves complex challenges where evidence can be limited and clinical guidelines may not address every situation. This resource was created to support clinicians and trainees by curating pharmacologic information focused on neuropsychiatry. Our goal is to simplify decision making by combining evidence-based data with clinical experience, particularly where conventional guidelines may fall short.
About the Creator
Developed by a clinician with experience in neuropsychiatry and psychopharmacology, this project was born out of a need for more nuanced, accessible medication reference tools tailored to complex cases.
Disclaimer
This site is for educational and training purposes only. It does not constitute medical advice and is not intended to replace clinical judgment or guidelines.
References
References for the information provided on this site are compiled in a comprehensive list below to maintain clarity and readability while ensuring transparency and access to source material.
Allida S, Cox KL, Hsieh CF, Lang H, House A, Hackett ML. Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke. Cochrane Database Syst Rev. 2020;1(1):CD003437. Published 2020 Jan 28. doi:10.1002/14651858.CD003437.pub4
Beedham W, Belli A, Ingaralingam S, Haque S, Upthegrove R. The management of depression following traumatic brain injury: A systematic review with meta-analysis. Brain Inj. 2020;34(10):1287-1304. doi:10.1080/02699052.2020.1797169
Berardelli I, Belvisi D, Pasquini M, Fabbrini A, Petrini F, Fabbrini G. Treatment of psychiatric disturbances in hypokinetic movement disorders. Expert Rev Neurother. 2019;19(10):965-981. doi:10.1080/14737175.2019.1636648
Chan KL, Campayo A, Moser DJ, Arndt S, Robinson RG. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. Arch Phys Med Rehabil. 2006;87(6):793-798. doi:10.1016/j.apmr.2006.02.016
Cheng YS, Tseng PT, Wu YC, et al. Therapeutic benefits of pharmacologic and nonpharmacologic treatments for depressive symptoms after traumatic brain injury: a systematic review and network meta-analysis. J Psychiatry Neurosci. 2021;46(1):E196-E207. Published 2021 Jan 21. doi:10.1503/jpn.190122
Cotter J, Muhlert N, Talwar A, Granger K. Examining the effectiveness of acetylcholinesterase inhibitors and stimulant-based medications for cognitive dysfunction in multiple sclerosis: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;86:99-107. doi:10.1016/j.neubiorev.2018.01.006
Cummings J, Lanctot K, Grossberg G, Ballard C. Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders: A Review. JAMA Neurol. 2024;81(6):645–653. doi:10.1001/jamaneurol.2024.0586
Hammock RG, Schroeder SR, Levine WR. The effect of clozapine on self-injurious behavior. J Autism Dev Disord. 1995;25(6):611-626. doi:10.1007/BF02178191
Hicks AJ, Clay FJ, Hopwood M, et al. Efficacy and Harms of Pharmacological Interventions for Anxiety after Traumatic Brain Injury: Systematic Review. J Neurotrauma. 2021;38(5):519-528. doi:10.1089/neu.2020.7277
Jenkins PO, De Simoni S, Bourke NJ, et al. Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging. Brain. 2019;142(8):2367-2379. doi:10.1093/brain/awz149
Kalbouneh HM, Toubasi AA, Albustanji FH, Obaid YY, Al-Harasis LM. Safety and Efficacy of SSRIs in Improving Poststroke Recovery: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2022;11(13):e025868. doi:10.1161/JAHA.122.025868
Khachatryan D, Groll D, Booij L, Sepehry AA, Schütz CG. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Gen Hosp Psychiatry. 2016;39:46-52. doi:10.1016/j.genhosppsych.2015.10.007
Kher H, Biddle KD, Donovan NJ. The Neuropsychiatry of Alzheimer’s Disease. In: Silbersweig DA, Safar LT, Daffner KR. eds. Neuropsychiatry and Behavioral Neurology: Principles and Practice. McGraw Hill; 2021.
Kim J, Keary CJ, Palumbo ML, Politte LC, McDougle CJ, Nowinski L. Intellectual Developmental Disorders. In: Silbersweig DA, Safar LT, Daffner KR. eds. Neuropsychiatry and Behavioral Neurology: Principles and Practice. McGraw Hill; 2021.
Knapp P, Campbell Burton CA, Holmes J, et al. Interventions for treating anxiety after stroke. Cochrane Database Syst Rev. 2017;5(5):CD008860. Published 2017 May 23. doi:10.1002/14651858.CD008860.pub3
Kreitzer N, Ancona R, McCullumsmith C, et al. The Effect of Antidepressants on Depression After Traumatic Brain Injury: A Meta-analysis. J Head Trauma Rehabil. 2019;34(3):E47-E54. doi:10.1097/HTR.0000000000000439
Lauterbach, M. D., Notarangelo, P. L., Nichols, S. J., Lane, K. S., & Koliatsos, V. E. (2015). Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice. Neuropsychiatric Disease and Treatment, 11, 1601–1607. https://doi.org/10.2147/NDT.S80457
Lee JH, Suzuki J. N-methyl-d-aspartate (NMDA) receptor antagonists for treatment of catatonia in adults: Narrative review. Gen Hosp Psychiatry. 2024;91:60-65. doi:10.1016/j.genhosppsych.2024.09.005
Maas AIR, Menon DK, Adelson PD, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16(12):987-1048. doi:10.1016/S1474-4422(17)30371-X
Mikami K, Jorge RE, Moser DJ, et al. Prevention of poststroke apathy using escitalopram or problem-solving therapy. Am J Geriatr Psychiatry. 2013;21(9):855-862. doi:10.1016/j.jagp.2012.07.003
Mueller C, Rajkumar AP, Wan YM, et al. Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease. CNS Drugs. 2018;32(7):621-635. doi:10.1007/s40263-018-0540-6
Nordness MF, Maiga AW, Wilson LD, et al. Effect of propranolol and clonidine after severe traumatic brain injury: a pilot randomized clinical trial. Crit Care. 2023;27(1):228. Published 2023 Jun 9. doi:10.1186/s13054-023-04479-6
Park, J. M., Kim, Y. W., Lee, S. C., & Yoon, S. Y. (2025). Efficacy of Methylphenidate in Patients With Brain Disease: A Systematic Review and Meta-Analysis. Brain & Neurorehabilitation, 18.
Pioro EP, Brooks BR, Cummings J, et al. Dextromethorphan plus ultra‑low‑dose quinidine reduces pseudobulbar affect. *Ann Neurol*. 2010;68(5):693‑702.
Ponsford J, Alway Y, Gould KR. Epidemiology and Natural History of Psychiatric Disorders After TBI. J Neuropsychiatry Clin Neurosci. 2018;30(4):262-270. doi:10.1176/appi.neuropsych.18040093
Rahmani E, Lemelle TM, Samarbafzadeh E, Kablinger AS. Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews. J Head Trauma Rehabil. 2021;36(4):E262-E283. doi:10.1097/HTR.0000000000000656
Raskind MA, Peskind ER, Chow B, et al. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. N Engl J Med. 2018;378(6):507-517. doi:10.1056/NEJMoa1507598
Safar LT, Gale S, Lonergan BB, Raj S, Erb J. Psychopharmacology in Neuropsychiatric Syndromes. In: Silbersweig DA, Safar LT, Daffner KR. eds. Neuropsychiatry and Behavioral Neurology: Principles and Practice. McGraw Hill; 2021.
Safar LT, Singhal T, Feng NC, Misasi E, Barker L. Neuropsychiatry of Multiple Sclerosis. In: Silbersweig DA, Safar LT, Daffner KR. eds. Neuropsychiatry and Behavioral Neurology: Principles and Practice. McGraw Hill; 2021.
Schwartz H, Sullivan J, Talmasov D, Safar LT. The Neuropsychiatry of Stroke. In: Silbersweig DA, Safar LT, Daffner KR. eds. Neuropsychiatry and Behavioral Neurology: Principles and Practice. McGraw Hill; 2021.
Singh N, Hazari PP, Mittal P, et al. Role of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and psychedelics in the treatment of major depressive disorder: A perspective on mechanistic insight and current status. Eur J Pharmacol. 2025;1001:177737. doi:10.1016/j.ejphar.2025.177737
Spauwen P, Ter Mors B, van Harten P, Domensino AF, Ponds R, van Heugten C. Efficacy and safety of amantadine as a treatment for apathy after brain injury: Two single-case experimental design studies. Neuropsychol Rehabil. 2022;32(6):872-896. doi:10.1080/09602011.2020.1842214
Spiegel, David R., et al. "Apathy due to cerebrovascular accidents successfully treated with methylphenidate: a case series." The Journal of neuropsychiatry and clinical neurosciences 21.2 (2009): 216-219.
Tani J, Wen YT, Hu CJ, Sung JY. Current and Potential Pharmacologic Therapies for Traumatic Brain Injury. Pharmaceuticals (Basel). 2022;15(7):838. Published 2022 Jul 6. doi:10.3390/ph15070838
Tay J; EFFECTS Trial Collaboration, Mårtensson B, Markus HS, Lundström E. Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the Efficacy oF Fluoxetine-a randomized Controlled Trial in Stroke trial data set. Int J Stroke. 2023;18(3):285-295. doi:10.1177/17474930221124760
Tay J, Morris RG, Markus HS. Apathy after stroke: Diagnosis, mechanisms, consequences, and treatment. Int J Stroke. 2021;16(5):510-518. doi:10.1177/1747493021990906
Urits I, Peck J, Orhurhu MS, et al. Off-label Antidepressant Use for Treatment and Management of Chronic Pain: Evolving Understanding and Comprehensive Review. Curr Pain Headache Rep. 2019;23(9):66. Published 2019 Jul 29. doi:10.1007/s11916-019-0803-z
Vasterling JJ, Jacob SN, Rasmusson A. Traumatic Brain Injury and Posttraumatic Stress Disorder: Conceptual, Diagnostic, and Therapeutic Considerations in the Context of Co-Occurrence. J Neuropsychiatry Clin Neurosci. 2018;30(2):91-100. doi:10.1176/appi.neuropsych.17090180
Weisholtz D, Sarkis R, Baslet G. Neuropsychiatry of Epilepsy. In: Silbersweig DA, Safar LT, Daffner KR. eds. Neuropsychiatry and Behavioral Neurology: Principles and Practice. McGraw Hill; 2021.
Wilson JE, Oldham MA, Francis A, et al. Catatonia: American Psychiatric Association Resource Document. Journal of the Academy of Consultation-Liaison Psychiatry. 2025; S2667-2960(25)00482-3. doi:10.1016/j.jaclp.2025.05.001.
Winstein CJ, Stein J, Arena R, et al. Guidelines for Adult Stroke Rehabilitation and Recovery: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [published correction appears in Stroke. 2017 Feb;48(2):e78. doi: 10.1161/STR.0000000000000120.]
Woranush W, Moskopp ML, Sedghi A, et al. Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review. Neuropsychiatr Dis Treat. 2021;17:3359-3377. Published 2021 Nov 19. doi:10.2147/NDT.S337865